Alaunos Therapeutics | ZIOP - Operating Expenses


Alaunos Therapeutics reported $1.19M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Alaunos Therapeutics USD 1.19M 428K Sep/2025
Amgen USD 5.9B 773M Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Biogen USD 1.88B 81.4M Sep/2025
Bioline Rx USD 2.63M 24K Sep/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Celltrion KRW 724.99B 6B Sep/2025
Corcept Therapeutics USD 197.42M 29.66M Sep/2025
Cspc Pharmaceutical CNY 5.4B 298.41M Sep/2025
Curis USD -13.99M 7.38M Jun/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Incyte USD 1.12B 3.53B Dec/2025
Intrexon USD 61.56M 26.1M Jun/2024
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
J&J USD 18.97B 2.38B Dec/2025
Kangmei Pharma CNY 1.39B 144.29M Sep/2025
Karyopharm Therapeutics USD 61.82M 3.24M Dec/2024
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 10.02M 9.78M Jun/2025
Merck USD 10.16B 558M Dec/2025
Neuren Pharmaceuticals AUD 8.69M 8.72M Jun/2025
Novartis USD 9.86B 115M Sep/2025
Organigram Holdings CAD 108.11M 17.03M Sep/2025
Ovoca Bio EUR 5.65M 3.45M Jun/2022
Pfizer USD 12.91B 79.89B Dec/2025
Pharma Mar EUR 39.62M 7.34M Sep/2025
PTC Therapeutics USD 246.3M 38.78M Dec/2025
Qiagen NV USD 418.54M 23.25M Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
Sartorius EUR 693.1M 29.4M Sep/2025
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
TG Therapeutics USD 132.34M 26.04M Sep/2025
Tilray USD 237.52M 17.34M Sep/2025
Verastem USD 37.03M 8.97M Sep/2024
Zz Pientze Pharmaceu CNY 1.55B 129.66M Sep/2025